Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06823947
PHASE1

Study of KK3910 in Healthy Volunteers and Patients With Essential Hypertension

Sponsor: Kyowa Kirin Co., Ltd.

View on ClinicalTrials.gov

Summary

Part 1 : To evaluate the safety of single-dose KK3910 in healthy volunteers. Part 2 : To evaluate the safety of multiple-dose KK3910 in patients with essential hypertension. Part 3 : To assess the safety profile of repeated dosing of KK3910 in an additional hypertension cohort.

Official title: A Phase 1, Placebo-Controlled, Double-Blind, Randomized, Single and Multiple Ascending-Dose Study of KK3910 in Healthy Volunteers and Patients With Essential Hypertension

Key Details

Gender

All

Age Range

18 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

160

Start Date

2025-04-03

Completion Date

2027-12

Last Updated

2026-03-09

Healthy Volunteers

Yes

Interventions

DRUG

Placebo

Placebo is administered single dose or multiple dose by SC injection.

DRUG

KK3910

KK3910 is administered single dose or multiple dose by SC injection.

Locations (3)

SOUSEIKAI PS Clinic

Hakata, Fukuoka, Japan

Medical Corporation Heishinkai OPHAC Hospital

Yodogawa, Osaka, Japan

Kitasato University Kitasato Institute Hospital

Minato-ku, Tokyo, Japan